Related Experiment Videos
Generalized eruptive lentiginosis induced by chemotherapy
1Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Clinical and Experimental Dermatology
|October 31, 2009
Summary
Cancer chemotherapy can rarely cause generalized lentiginosis, a condition of brown macules resulting from melanocyte proliferation. This case highlights an unusual side effect of cancer treatment.
Area of Science:
- Dermatology
- Oncology
- Pharmacology
Background:
- Lentigines are brown macules caused by melanocyte proliferation at the dermoepidermal junction.
- Generalized lentiginosis is a known side effect of certain medications, including immunosuppressants and immunomodulators.
Observation:
- This report details an extremely rare instance of lentiginosis.
- The lentiginosis was observed as a direct consequence of cancer chemotherapy.
Findings:
- Cancer chemotherapy can induce generalized lentiginosis.
- This represents a previously undocumented adverse drug reaction in the context of cancer treatment.
Implications:
- Clinicians should consider chemotherapy-induced lentiginosis in patients presenting with new-onset generalized lentigines.
- Further research is warranted to understand the mechanisms and prevalence of this rare side effect.
